Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency

计划入组 300 人 · 首次发布于 2014 年 5 月 28 日

Renal Osteodystrophy: A Fresh Approach

计划入组 464 人 · 首次发布于 2009 年 3 月 11 日

Precision Medicine Approaches to Renal Osteodystrophy

计划入组 40 人 · 首次发布于 2023 年 5 月 30 日

HyperAcute Renal

Renal Fibrosis(Hepion)

Renal disease(SKIP)

River 3 Renal Corp.

United States

Southeast Renal Research Institute

United States

RIVER 2 RENAL CORP.

United States

Unicycive Submits NDA to FDA for Oxylanthanum Carbonate to Treat Hyperphosphatemia in CKD Patients on Dialysis

FDA Accepts Unicycive's Oxylanthanum Carbonate (OLC) Application for Hyperphosphatemia Treatment

FDA Accepts Unicycive's NDA for Oxylanthanum Carbonate to Treat Hyperphosphatemia in CKD Patients on Dialysis